Commit To Purchase Verve Therapeutics At $5, Earn 54.8% Annualized Using Options
February 25, 2025 at 13:52 PM EST
Investors eyeing a purchase of Verve Therapeutics Inc (VERV) stock, but cautious about paying the going market price of $6.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $5 strike, which has a bid at the time of this writing of 60 cents..
